EPIS® Právní systém | Plné znění

NAŘÍZENÍ KOMISE X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

ze xxx 16. února 2022,

xxxxxx xx pro účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (ES) x.&xxxx;1272/2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí

(Text x&xxxx;xxxxxxxx xxx EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Evropské unie,

s ohledem xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx látek x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX a o změně xxxxxxxx (ES) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx na xx.&xxxx;37 xxxx.&xxxx;5 xxxxxxxxx nařízení,

vzhledem x&xxxx;xxxxx důvodům:

(1)	Tabulka 3 x&xxxx;xxxxx 3 přílohy XX xxxxxxxx (ES) x.&xxxx;1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx látek xx xxxxxxx kritérií xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx X&xxxx;xxxxxxxxx xxxxxxxx.

(2)

Xxxxxxxx agentuře xxx xxxxxxxx xxxxx (xxxx xxx „agentura“) byly x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxxxx xxxxxx na xxxxxxxx xxxxxxxxxxxxx klasifikace x&xxxx;xxxxxxxx xxxxxxxxx xxxxx a na xxxxxxxxxxx xxxx zrušení xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxxx látek. Xxxx, xx Výbor xxx xxxxxxxxxx rizik (XXX) xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxx, xxxxxx k těmto xxxxxxx xxxxxxxxxxx xxxxxxxxxx&xxxx;(2):

—	xxxxxxxxxx ze xxx 5.&xxxx;xxxxxxxx&xxxx;2019 pro xxxxxxxxx, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx,

—	xxxxxxxxxx xx xxx 4. května 2020 xxx xxxxxxxxxx (ISO), [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx dne 4.&xxxx;xxxxxx&xxxx;2020 xxx β-xxxxxxxxxx (ISO); xxxxxxx xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1S,3R)-3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropan-1-karboxylát,

—	stanovisko ze xxx 4. května 2020 xxx xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxx,

—	xxxxxxxxxx xx xxx 11. června 2020 xxx xxxx telluričitý,

—	stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—	xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-butoxyethoxy)ethoxy]methyl}-6-propyl-1,3-benzodioxol,

—	stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxx,

—	xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 pro exo-1,7,7-trimethylbicyklo[2.2.1]hept-2-yl-akrylát; xxxxxxxxx-xxxxxxx,

—	xxxxxxxxxx ze dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxx (XXX); 4-(2,2-dimethylhydrazino)-4-oxobutanovou xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx xxxxxxxx,

—	xxxxxxxxxx xx xxx 11. června 2020 xxx xxxxxxxxxxx (ISO); 3,6-bis(o-chlorfenyl)-1,2,4,5-tetrazin,

—	stanovisko xx xxx 11. června 2020 xxx fluopikolid (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro trichlorsilan,

—	stanovisko xx xxx 11. června 2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

—	xxxxxxxxxx xx xxx 11. června 2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx {[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctové xxxxxxxx x&xxxx;xxxxxx pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Xxxxxxxx xxxxxx,

—	xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—	xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxxxxxxx,

—	xxxxxxxxxx xx dne 17. září 2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—	xxxxxxxxxx xx xxx 17. září 2020 xxx xxxxxxxxxxx (ISO); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 4,4’-xxxxx(xxxxxxxxxxxxxxxxxxxxx),

—	xxxxxxxxxx xx dne 17. září 2020 xxx xxxxxx-4-xxxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 17. září 2020 xxx xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx,

—	xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX],

—	xxxxxxxxxx xx xxx 17. září 2020 xxx 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI],

—	stanovisko ze xxx 17. září 2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxx,

—	xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 2-ethyl-2-{[(1-oxoallyl)oxy]methyl}propan-1,3-diyl-diakrylát; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; xxxxxxxxxxxxxxxxx-xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx < 0,1 % xxxx. xxxxxx s aerodynamickým xxxxxxxx xxxxxx než 50 μx],

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx ≥ 0,1 % xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μx],

—	xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxx amonný,

—	stanovisko ze xxx 8. října 2020 xxx 2,4,6-xxx-xxxx-xxxxxxxxxx,

—	xxxxxxxxxx xx dne 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxxxx (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx,

—	xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxx-2-xxxxx-1-xxxx, sodnou xxx; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx sodný,

—	stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; isoflucypram,

—	stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 pro 4,4′-xxxxxxxxxxxxxxxxxxxx; bisfenol X,

—	xxxxxxxxxx xx dne 8. října 2020 xxx xxxxxxxxxxxxx (ISO); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—	xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 xxx dimoxystrobin (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx,

—	xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro 2-{N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino}ethyl-acetát; X.X. Disperse Xxxx 124,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro kyselinu xxxxxxxxxxxxxxxxxx; kyselinu xxxxxxxxxxxxxxxxxxxxxx,

—	xxxxxxxxxx xx dne 10. prosince 2020 xxx xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; xxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, sodné x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx soli,

—	stanovisko ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X10-X13, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanovou xxxxxxxx,

—	xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx kyselinu,

—	stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-xxxxxxx-2,4,6-xxxxxxx; melamin,

—

stanovisko xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxx směs: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [relativní xxxxx ≥ 78 % xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx,

—	xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxx, xxxxxxxx [x&xxxx;xxxxx rostliny Azadirachta xxxxxx, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx],

—	xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx oxid xxxxxxxxx,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro xxxxxxxx (XXX), 3-xxxxxxxxx-2,1,3-xxxxxxxxxxxxxxx-4-xx-2,2-xxxxxx,

—	xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 ohledně xxxxxxxxxx xxxxxxxxx nových xxxxxxxxx x&xxxx;xxxxxx inhalační xxxxxxxx 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) na xxxxxx Xxxxxxxx xxxxxx.

(3)

Xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx, které xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx ve xxxxxxxxxxxx XXX xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro 2-xxxxxxxxxxxxxx xxxxxxxx a její soli; xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx opětovného posouzení xxxxxxxx toxicity {[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctové xxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Xxxxxxxx komise, xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx xxxxxx, xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx oxid xxxxxxxxx, xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxx informací o akutní xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Evropské xxxxxx x&xxxx;xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxx.

(4)

Xxxxxx tyto xxxxxxxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx je za xxxxxxxxxx k tomu, aby xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx xx xxxxxxxxxxxx XXX. Xx xxxxxxx xxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx xx xxxxx xxxxxx zavést, xxxxxxxxxxxx xxxx xxxxxx harmonizovanou xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx.

(5)

Xxxx, xx bylo Xxxxxx předáno xxxxxxxxxx XXX, xxxx xxxxxxxx xxxxxxxxx informace týkající xx xxxxxx xxxxxxxxx xxxxxxxx silanaminu, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx hydrolýzy s oxidem xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx oxidu křemičitého x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx. Xxxxxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx s oxidem xxxxxxxxxx; xxxxxxxxxxx syntetického xxxxxxxxx oxidu xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx úpravou xxxx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx 2, xxxxxxxxxx xx xxxxxxxxxx XXX xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019, xx neměla xxx xxxxxxxx do xxxxxxx VI xxxxxxxx (XX) x.&xxxx;1272/2008, neboť Xxxxxx nové vědecké xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx, xx xx xxxx xxxxx xxxxx posouzení XXX. Xx přílohy XX nařízení (ES) x.&xxxx;1272/2008 by xxxx xxxx xxx zařazena xxxxxxxxxxx xxxx látky xxxx XXXX RE 2, doporučená xx xxxxxxxxxx výboru XXX xx dne 5. prosince 2019, xxxxx nebyly xxxxxxxx xxxxx xxxx informace, xxxxx xx xxxxxxxxxx xxxxx xxxxxxxxx xxxx xxxxxxxxxxx.

(6)	Xxxxxxxx (ES) č. 1272/2008 xx xxxxx xxxx xxx odpovídajícím způsobem xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx nebo xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx klasifikací xx nemělo xxx xxxxxxxxxx ihned, xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx xxxx xx to, xxx přizpůsobili xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx xxxxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxx a prodali xxxxxxxxx xxxxxx, xx které xx xxxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Tato xxxx xx xxxxxx xxxxxxxx k tomu, xxx xxxxxxxxxx xxxx xxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxxx x&xxxx;xxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx, xxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxx xxxxxxxxxxx xxxxx xxxxxx xxxxxxxx. Xxxxxxxxxxx by xxxx xxxx být xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx způsobem přizpůsobit xxxxxxxxxx a balení na xxxxxxxxxxx xxxxxxx xxxx xxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxx, xxx byla xxxxxxxxx xxxxxx xxxxxx xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxxxxx prostředí x&xxxx;xxx xx dodavatelům xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (ES) x.&xxxx;1272/2008

Xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 xx xxxx v souladu x&xxxx;xxxxxxxx xxxxxx nařízení.

Článek 2

Vstup v platnost x&xxxx;xxxxxxxxxxxx

Xxxx xxxxxxxx xxxxxxxx v platnost xxxxxxxx xxxx xx xxxxxxxxx v Úředním xxxxxxxx Xxxxxxxx unie.

Použije xx xxx dne 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx xxxxxx xxxxx být látky x&xxxx;xxxxx klasifikovány, označovány x&xxxx;xxxxxx v souladu s tímto xxxxxxxxx xxx dne xxxx xxxxxx x&xxxx;xxxxxxxx.

Toto xxxxxxxx xx xxxxxxx v celém xxxxxxx x&xxxx;xxxxx xxxxxxxxxx ve xxxxx xxxxxxxxx xxxxxxx.

X&xxxx;Xxxxxxx xxx 16.&xxxx;xxxxx 2022.

Za Xxxxxx

xxxxxxxxxxx

Xxxxxx VON DER XXXXX

(1)&xxxx;&xxxx;Xx. věst. L 353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxxxx jsou xxxxxxxx xx této xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/. – Xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 x&xxxx;xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 týkající xx xxxxxxxxxx posouzení xx xxxxxx Xxxxxxxx xxxxxx xxxx x&xxxx;xxxxxxxxx xx xxxx internetové xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

XXXXXXX

Xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx xxxxx:

x&xxxx;xxxxx 3 xx xxxxxxx 3 xxxx xxxxx:

xxxxxxxx se xxxx xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX	Xxxxxxxx
Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx standardních xxx o nebezpečnosti	Kódy xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx		Xxxxxxxx
„014-052-00-7	xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx s oxidem křemičitým; xxxxxxxxx xxxxxxxxxx amorfní xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx	272-697-1	68909-20-6	XXXX RE 2	X373 (plíce) (xxxxxxxxxx)	XXX08 Xxx	X373 (xxxxx) (vdechování)	EUH066“
„035-005-00-7	bromid xxxxxx	235-183-8	12124-97-9	Xxxx. 1X Xxxx. XXXX XX 3 XXXX XX 1 Xxx Xxxxx. 2	X360XX X362 X336 X372 (xxxxxxx xxxxxx) X319	XXX08 XXX07 Xxx	X360XX X362 X336 X372 (xxxxxxx xxxxxx) X319“
„050-032-00-4	xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx)	220-481-2	2781-10-4	Xxxx. 2 Xxxx. 1X XXXX XX 1	H341 H360FD H372 (xxxxxxxx xxxxxx)	XXX08 Xxx	X341 X360XX X372 (xxxxxxxx xxxxxx)“
„050-033-00-X	xxxxxxxxxx-xxxxxxxx	213-928-8	1067-33-0	Xxxx. 2 Xxxx. 1B STOT XX 1	H341 H360FD H372 (xxxxxxxx xxxxxx)	XXX08 Xxx	X341 X360XX X372 (xxxxxxxx systém)“
„052-001-00-0	tellur	236-813-4	13494-80-9	Repr. 1X Xxxx.	X360Xx X362	XXX08 Xxx	X360Xx X362“
„052-002-00-6	xxxx telluričitý	231-193-1	7446-07-3	Repr. 1X Xxxx.	X360Xx X362	XXX08 Xxx	X360Xx X362“
„056-005-00-3	xxxxxxxxx xxxxxxx-xxxxxxxx	237-222-4	13701-59-2	Xxxx. 1X Xxxxx Xxx. 4 Xxxxx Tox. 3	X360XX X332 X301	XXX08 XXX06 Xxx	X360XX X332 X301		xxxxxxxxx: XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx nebo xxxx) xxxxxx: XXX&xxxx;= 100&xxxx;xx/xx XX“
„601-097-00-8	xxxxxxxxxxxx	203-132-9	103-65-1	Xxxx. Xxx. 3 Xxx. Tox. 1 XXXX XX 3 Xxxxxxx Xxxxxxx 2	X226 X304 X335 X411	XXX02 XXX08 XXX07 XXX09 Xxx	X226 X304 X335 X411“
„603-243-00-6	xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx	253-057-0	36483-57-5; 1522-92-5	Carc. 1X Xxxx. 2	X350 X341	XXX08 Xxx	X350 X341“
„604-096-00-0	xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx	200-076-7	51-03-6	XXXX XX 3 Xxx Xxxxx. 2 Xxxxxxx Acute 1 Aquatic Xxxxxxx 1	X335 X319 X400 X410	XXX07 XXX09 Xxx	X335 X319 X410	XXX066	X&xxxx;= 1 X&xxxx;= 1“
„604-097-00-6	2,4,6-xxx-xxxx-xxxxxxxxxx	211-989-5	732-26-3	Xxxx. 1X Xxxxx Xxx. 4 XXXX XX 2 Xxxx Xxxx. 1X	X360X X302 X373 (xxxxx) X317	XXX08 XXX07 Xxx	X360X X302 X373 (xxxxx) X317		xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx TH“
„604-098-00-1	4,4’-sulfonyldifenol; xxxxxxxx X	201-250-5	80-09-1	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„606-153-00-5	xxxxxxxxxx	204-337-6	119-61-9	Xxxx. 1X	X350	XXX08 Xxx	X350“
„606-154-00-0	xxxxxxxxxxx (ISO); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx	220-529-2	2797-51-5	Xxxx. 2 Xxxx. 2 Xxxxx Xxx. 4 XXXX XX 2 Xxx Xxxxx. 2 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H351 H361d H302 H373 (krevní xxxx, ledviny) H319 H317 H400 H410	GHS08 GHS07 GHS09 Wng	H351 H361d H302 H373 (krevní xxxx, xxxxxxx) X319 X317 X410		xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„607-756-00-6	xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx	227-561-6	5888-33-5	Xxxx Xxxx. 1&xxxx;X	X317	XXX07 Xxx	X317“
„607-757-00-1	xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx	216-485-9	1596-84-5	Xxxx. 2	X351	XXX08 Xxx	X351“
„607-758-00-7	4,4′-xxxxx(xxxxxxxxxxxxxxxxxxxxx)	201-286-1	80-51-3	Xxxx-xxxxx. X Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X242 X400 X410	XXX02 XXX09 Xxx	X242 X410		X&xxxx;= 1 X&xxxx;= 1“
„607-759-00-2	xxxxxx-4-xxxxxxxxxxxxxxx	216-407-3	1576-35-8	Xxxx-xxxxx. X	X242	XXX02 Xxx	X242“
„607-760-00-8	2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Xxxx 124	239-203-6	15141-18-1	Xxxx Xxxx. 1&xxxx;X	X317	XXX07 Xxx	X317		Xxxx Xxxx. 1&xxxx;X; X317: C ≥ 0,001 %“
„607-761-00-3	perfluorheptanová xxxxxxxx; xxxxxxxxxxxxxxxxxxxxx kyselina	206-798-9	375-85-9	Repr. 1X XXXX XX 1	X360X X372 (xxxxx)	XXX08 Xxx	X360X X372 (xxxxx)“
„607-762-00-9	xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; valifenalát	-	283159-90-0	Carc. 2 Xxxxxxx Xxxxxxx 2	X351 X411	XXX08 XXX09 Xxx	X351 X411“
„607-763-00-4	6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx, xxxxx a tris(2-hydroxyethyl)amonné soli	-	-	Repr. 1X Xxx Irrit. 2	H360FD H319	GHS08 GHS07 Dgr	H360FD H319“
„607-764-00-X	6-[alkyl-(C10-C13, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanová xxxxxxxx	-	2156592-54-8	Xxxx. 1X Xxx Irrit. 2	H360FD H319	GHS08 GHS07 Dgr	H360FD H319“
„607-765-00-5	6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx	-	-	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„613-341-00-0	xxxxxxxxxxx (ISO); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx	277-728-2	74115-24-5	Xxxxxxx Xxxxxxx 1	H410	GHS09 Wng	H410		M = 1“
„613-342-00-6	theofylin; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx	200-385-7	58-55-9	Xxxx. 1B	H360D	GHS08 Dgr	H360D“
„613-343-00-1	pyridalyl (ISO); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx	-	179101-81-6	Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Aquatic Chronic 1	X317 X400 X410	XXX07 XXX09 Xxx	X317 X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„613-344-00-7	pyridin-2-thiol-1-oxid, xxxxx xxx; xxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx	223-296-5; 240-062-8	3811-73-2; 15922-78-8	Xxxxx Tox. 3 Xxxxx Xxx. 3 Xxxxx Tox. 4 XXXX XX 1 Skin Xxxxx. 2 Xxx Irrit. 2 Xxxx Sens. 1 Xxxxxxx Xxxxx 1 Aquatic Chronic 2	X331 X311 X302 X372 (xxxxxxx xxxxxx) X315 X319 X317 X400 X411	XXX06 XXX08 XXX09 Xxx	X331 X311 X302 X372 (xxxxxxx xxxxxx) X315 X319 X317 X410	XXX070	xxxxxxxxx: XXX&xxxx;= 0,5 mg/l (xxxxx nebo mlha) dermální: ATE = 790&xxxx;xx/xx TH orální: ATE = 500&xxxx;xx/xx XX X&xxxx;= 100“
„613-345-00-2	1,3,5-triazin-2,4,6-triamin; melamin	203-615-4	108-78-1	Carc. 2 XXXX XX 2	H351 H373 (xxxxxx xxxxx)	XXX08 Xxx	X351 X373 (močové xxxxx)“
„615-046-00-2	1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX]	220-474-4	2778-42-9	Xxxx. Xxxx. 1 Xxxx Xxxx. 1&xxxx;X	X334 X317	XXX08 Xxx	X334 X317“
„615-047-00-8	1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [x-XXX]	222-852-4	3634-83-1	Xxxx. Xxxx. 1 Skin Xxxx. 1&xxxx;X	X334 X317	XXX08 Xxx	X334 X317		Xxxx Sens. 1&xxxx;X; X317: C ≥ 0,001 %“
„615-048-00-3	2,4,6-triisopropyl-m-fenylen-diisokyanát	218-485-4	2162-73-4	Resp. Xxxx. 1 Xxxx Xxxx. 1	X334 X317	XXX08 Xxx	X334 X317“
„615-049-00-9	1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% hmot. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μm]	221-641-4	3173-72-6	STOT XX 3 Xxxx Xxxxx. 2 Xxx Xxxxx. 2 Xxxx. Xxxx. 1 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxxxx 3	X335 X315 X319 X334 X317 X412	XXX07 XXX08 Xxx	X335 X315 X319 X334 X317 X412“
„615-050-00-4	1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx průměrem xxxxxx xxx 50 μm]	221-641-4	3173-72-6	Acute Xxx. 2 XXXX SE 3 Xxxx Xxxxx. 2 Xxx Xxxxx. 2 Xxxx. Sens. 1 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxxxx 3	H330 H335 H315 H319 H334 H317 H412	GHS06 GHS08 Dgr	H330 H335 H315 H319 H334 H317 H412		inhalační: ATE = 0,27 mg/l (xxxxx nebo mlha)“
„616-237-00-3	fluopikolid (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx	-	239110-15-7	Xxxx. 2	H361d	GHS08 Wng	H361d“
„616-238-00-9	triamid xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx	477-690-9	874819-71-3	Xxxx. 1X XXXX XX 2	X360Xx X373 (xxxxxxx)	XXX08 Xxx	X360Xx X373 (xxxxxxx)“
„616-239-00-4	X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx	-	1255734-28-1	Xxxx. 2 Xxxxx Xxx. 4 Xxxx Sens. 1X Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X361x X332 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X361x X332 X317 X410		xxxxxxxxx: XXX&xxxx;= 2,2 mg/l (xxxxx xxxx xxxx) X&xxxx;= 10 X&xxxx;= 1“
„616-240-00-X	xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], isopyrazam	-	881685-58-1	Carc. 2 Xxxx. 1X Xxxx Sens. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X360X X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X360X X317 X410		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;% X&xxxx;= 10 X&xxxx;= 10“
„650-058-00-1	Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Azadirachta indica, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx]	283-644-7	84696-25-3	Xxxx. 2 Xxxx Sens. 1 Xxxxxxx Xxxxxxx 1	X361x X317 X410	XXX08 XXX07 XXX09 Xxx	X361x X317 X410		X&xxxx;= 10“

xxxxxxx xxxxxxxxxxxx indexovým xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 se xxxxxxxxx xxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE	Poznámky
Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Kódy xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx a signálních xxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx doplň. xxxxxxxxxxxx xxx o nebezpečnosti	Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE	Poznámky
„014-001-00-9	trichlorsilan	233-042-5	10025-78-2	Flam. Xxx. 1 Xxxxx-xxxxx. 1 Xxxxx Xxx. 3 Xxxxx Tox. 4 Skin Xxxx. 1&xxxx;X Xxx Xxx. 1	X224 X260 X331 X302 X314 X318	XXX02 XXX06 XXX05 Xxx	X224 X260 X331 X302 X314	XXX014 XXX029 XXX071	xxxxxxxxx: XXX&xxxx;= 7,6 mg/l (páry) orální: ATE = 1&xxxx;000 mg/kg XX“
„023-001-00-8	xxxx xxxxxxxxx	215-239-8	1314-62-1	Xxxx. 2 Xxxx. 1B Repr. 2 Xxxx. Xxxxx Tox. 3 Xxxxx Xxx. 2 STOT SE 3 XXXX XX 1 Aquatic Xxxxxxx 2	X341 X350 X361xx X362 X301 X330 X335 X372 (dýchací xxxxx, xxxxxxxxxx) X411	XXX06 XXX08 XXX09 Xxx	X341 X350 X361xx X362 X301 X330 X335 X372 (xxxxxxx xxxxx, vdechování) H411		inhalační: ATE = 0,05&xxxx;xx/x (xxxxx xxxx xxxx) xxxxxx: XXX&xxxx;= 220&xxxx;xx/xx XX“
„601-024-00-X	xxxxx	202-704-5	98-82-8	Xxxx. Liq. 3 Xxxx. 1B Asp. Xxx. 1 XXXX XX 3 Aquatic Xxxxxxx 2	H226 H350 H304 H335 H411	GHS02 GHS08 GHS07 GHS09 Dgr	H226 H350 H304 H335 H411“
„603-014-00-0	2-butoxyethan-1-ol; ethylenglykol-monobutyl-ether	203-905-0	111-76-2	Acute Xxx. 3 Xxxxx Xxx. 4 Xxxx Xxxxx. 2 Xxx Xxxxx. 2	X331 X302 X315 X319	XXX06 Xxx	X331 X302 X315 X319		xxxxxxxxx: XXX&xxxx;= 3&xxxx;xx/x (xxxx) xxxxxx: XXX&xxxx;= 1 200 &xxxx;xx/xx XX“
„603-107-00-6	2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx	203-906-6	111-77-3	Xxxx. 1X	X360X	XXX08 Xxx	X360X		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%“
„604-030-00-0	4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X	201-245-8	80-05-7	Xxxx. 1X XXXX XX 3 Eye Xxx. 1 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X335 X318 X317 X400 X410	XXX08 XXX07 XXX05 XXX09 Xxx	X360X X335 X318 X317 X410		X&xxxx;= 1 M = 10“
„607-111-00-9	2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; xxxxxxxxxxxxxxxxx-xxxxxxxxxx	239-701-3	15625-89-5	Xxxx. 2 Xxxx Xxxxx. 2 Xxx Xxxxx. 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X315 X319 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X315 X319 X317 X410		X&xxxx;= 1 X&xxxx;= 1	D“
„607-230-00-6	2-ethylhexanová kyselina x&xxxx;xxxx soli, x&xxxx;xxxxxxxx xxxx, které xxxx xxxxxxx xxxxx x&xxxx;xxxx xxxxxxx	-	-	Xxxx. 1X	X360X	XXX08 Xxx	X360X“
„607-253-00-1	xxxxxxxxxx (XXX); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx	269-855-7	68359-37-5	Xxxx. Xxxxx Xxx. 2 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	H362 H330 H300 H370 (xxxxxxx xxxxxx) X400 X410	XXX06 XXX08 XXX09 Xxx	X362 X330 X300 X370 (xxxxxxx systém) H410		inhalační: ATE = 0,14&xxxx;xx/x (prach xxxx xxxx) xxxxxx: XXX&xxxx;= 14&xxxx;xx/xx XX X&xxxx;= 1&xxxx;000&xxxx;000 X&xxxx;= 1 000 000 “
„607-254-00-7	β-xxxxxxxxxx (XXX); xxxxxxx xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx	-	1820573-27-0	Xxxx. Xxxxx Xxx. 2 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H362 H330 H300 H370 (xxxxxxx xxxxxx) X400 X410	XXX06 XXX08 XXX09 Xxx	X362 X330 X300 X370 (xxxxxxx xxxxxx) X410		xxxxxxxxx: XXX&xxxx;= 0,081 mg/l (prach xxxx xxxx) xxxxxx: XXX&xxxx;= 11&xxxx;xx/xx XX X&xxxx;= 1&xxxx;000&xxxx;000 X&xxxx;= 1&xxxx;000&xxxx;000 “
„607-734-00-6	xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx	404-290-3	7216-95-7	Xxxx. 1X Xxxxx Xxx. 4 XXXX RE 2 Xxx Xxxxx. 2	X360X X332 X373 (xxxxxxxxxx) X319	XXX08 XXX07 Xxx	X360X X332 X373 (xxxxxxxxxx) X319		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;% xxxxxxxxx: XXX&xxxx;= 1,5 mg/l (xxxxx xxxx xxxx)“
„607-735-00-1	{[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx	200-652-8	67-43-6	Xxxx. 1X Xxxxx Xxx. 4 XXXX XX 2 Xxx Xxxxx. 2	X360X X332 X373 (xxxxxxxxxx) X319	XXX08 XXX07 Xxx	X360X X332 X373 (xxxxxxxxxx) X319		Xxxx. 1X; H360D: X&xxxx;≥&xxxx;3&xxxx;% xxxxxxxxx: XXX&xxxx;= 1,5&xxxx;xx/x (prach xxxx xxxx)“
„607-736-00-7	xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]	205-391-3	140-01-2	Xxxx. 1B Acute Xxx. 4 STOT XX 2	X360X X332 X373 (xxxxxxxxxx)	XXX08 XXX07 Xxx	X360X X332 X373 (xxxxxxxxxx)		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;% xxxxxxxxx: XXX&xxxx;= 1,5&xxxx;xx/x (prach xxxx xxxx)“
„608-032-00-2	xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx	-	135410-20-7&xxxx;160430-64-8	Xxxx. 2 Xxxxx Tox. 3 Xxxxxxx Xxxxxxx 1 Xxxxxxx Xxxxx 1	X361x X301 X410 X400	XXX08 XXX06 XXX09 Xxx	X361x X301 X410		xxxxxx: XXX&xxxx;= 140&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„609-042-00-X	pendimethalin (XXX); N-(1-ethylpropyl)-2,6-dinitro-3,4-xyliden	254-938-2	40487-42-1	Repr. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X361x X400 X410	XXX08 XXX09 Xxx	X361x X410		X&xxxx;= 100 X&xxxx;= 10“
„613-012-00-1	bentazon (XXX); 3-xxxxxxxxx-1X-2,1,3-xxxxxxxxxxxxxxx-4(3X)-xx-2,2-xxxxxx	246-585-8	25057-89-0	Xxxx. 2 Xxxxx Xxx. 4 Xxx Irrit. 2 Xxxx Xxxx. 1	H361d H302 H319 H317	GHS08 GHS07 Wng	H361d H302 H319 H317		orální: XXX&xxxx;= 1 600 &xxxx;xx/xx XX“
„616-164-00-7	xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx		149961-52-4	Xxxx. 2 Xxxx. 2 Xxxxx Xxx. 4 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X361x X332 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X361x X332 X410		xxxxxxxxx: XXX&xxxx;= 1,3&xxxx;xx/x (xxxxx xxxx xxxx) X&xxxx;= 100 X&xxxx;= 100“

c)	položka xxxxxxxxxxxx xxxxxxxxxx xxxxx 615-007-00-X xx zrušuje.

Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

NAŘÍZENÍ KOMISE X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

ze xxx 16. února 2022,

xxxxxx xx pro účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (ES) x.&xxxx;1272/2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí

Xxxxxx&xxxx;1

Článek 2

Vstup v platnost x&xxxx;xxxxxxxxxxxx

XXXXXXX

Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

NAŘÍZENÍ KOMISE X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

ze xxx 16. února 2022,

xxxxxx xx pro účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (ES) x.&xxxx;1272/2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí

Xxxxxx&xxxx;1

Článek 2

Vstup v platnost x&xxxx;xxxxxxxxxxxx

XXXXXXX

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.